 of the two surveillance strategies at 18 months found no
differences in primary, primary assisted, or secondary patency.
A smaller study from Sweden randomized 156 patients
with lower extremity arterial reconstructions to intensive
surveillance to include DUS (n ¼ 79) vs routine clinical
surveillance (n ¼ 77).247 Forty grafts, equally distributed
between the two groups, were PTFE grafts. Only two